Eikon Therapeutics Announces $517.8 Million Series B Raise And Expansion Of Executive Leadership Team
Amount Raised
$518 Million
Round Type
Series B
MillbraeBiotechnologyHealth CareTherapeuticsDescription
Eikon Therapeutics, Inc., a pioneer in the application of live-cell super-resolution microscopy to drug discovery, today announced that it has closed a $517.8 million Series B financing. Since its founding two years ago, Eikon Therapeutics has raised more than $668 million to advance its mission of inventing new therapies that address grievous illness.
Quick answer
Eikon Therapeutics raised $518 Million in a Series B round, dated January 6, 2022. Eikon Therapeutics is based in Millbrae, California, United States.
- How much did Eikon Therapeutics raise?
- Eikon Therapeutics raised $518 Million in a Series B round on January 6, 2022.
- What does Eikon Therapeutics do?
- Eikon Therapeutics is advancing breakthrough therapies through the purposeful integration of science and engineering.
- Where is Eikon Therapeutics based and how big is it?
- Eikon Therapeutics is based in Millbrae, California, United States. Fundz records about 390 employees.
- Who are the decision-makers at Eikon Therapeutics?
- Fundz holds 1 contact at Eikon Therapeutics, including the Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Eikon Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Azora Therapeutics, Inc. (DE) raised $10M on February 17, 2022.
- Centaurus Therapeutics raised $31M (Series A) on February 16, 2022.
- Azora Therapeutics, Inc. (DE) raised $10M (Funding Round) on February 16, 2022.
- Arsenal Biosciences raised $221M on February 10, 2022.
- MindImmune Therapeutics raised $5.3M on February 4, 2022.
- Passage Bio raised $4M (Seed) on February 1, 2022.
Who to call at Eikon Therapeutics, and when
A new round usually means Eikon Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Eikon Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Eikon Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Eikon Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Eikon Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansEikon Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.